These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12192254)

  • 41. Rational use of new and existing disease-modifying agents in rheumatoid arthritis.
    Kremer JM
    Ann Intern Med; 2001 Apr; 134(8):695-706. PubMed ID: 11304108
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Scleroderma in childhood.
    Ansell BM; Nasseh GA; Bywaters EG
    Ann Rheum Dis; 1976 Jun; 35(3):189-97. PubMed ID: 984898
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of immunomodulating therapy in systemic sclerosis.
    van den Hoogen FH; Boerbooms AM; van de Putte LB
    Clin Rheumatol; 1990 Sep; 9(3):319-24. PubMed ID: 2124530
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methotrexate-induced accelerated nodulosis in a patient with rheumatoid arthritis and scleroderma.
    Motegi S; Ishikawa O
    Acta Derm Venereol; 2014 May; 94(3):357-8. PubMed ID: 24158350
    [No Abstract]   [Full Text] [Related]  

  • 45. Diffuse systemic sclerosis presenting as Meniere's disease-like symptoms as part of autoimmune inner ear disease.
    Feld J; Shupak A; Zisman D
    Isr Med Assoc J; 2015 Apr; 17(4):263-4. PubMed ID: 26040060
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment of systemic sclerosis].
    van den Hoogen FH
    Z Rheumatol; 2006 Jul; 65(4):306, 308-10. PubMed ID: 16819640
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclophosphamide therapy for scleroderma.
    Akesson A
    Curr Opin Rheumatol; 1998 Nov; 10(6):579-83. PubMed ID: 9812219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Thermography with liquid crystal in scleroderma].
    Tauchmannová H; Hajzok O
    Z Rheumatol; 1977; 36(9-10):299-394. PubMed ID: 930425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Scleroderma: therapeutic options.
    Connolly SM
    Cutis; 1984 Sep; 34(3):274-6. PubMed ID: 6386354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of scleroderma.
    Sapadin AN; Fleischmajer R
    Arch Dermatol; 2002 Jan; 138(1):99-105. PubMed ID: 11790173
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thymoglobulin and cyclophosphamide as treatment for diffuse cutaneous systemic sclerosis.
    Holmberg LA; Furst DE; McSweeney PA; Nash RA
    J Rheumatol; 2009 Aug; 36(8):1839. PubMed ID: 19671826
    [No Abstract]   [Full Text] [Related]  

  • 52. [Advances in the treatment of scleroderma].
    Marquet R; Vilardell M
    Med Clin (Barc); 1984 Jun; 83(2):74-7. PubMed ID: 6147448
    [No Abstract]   [Full Text] [Related]  

  • 53. Combination vasodilator therapy improves skin microvascular blood but do not restore endothelial function in systemic sclerosis.
    Hariri G; Laurent C; Lavillegrand JR; Riviere S; Joffre J; Guidet B; Fain O; Mekinian A; Ait-Oufella H
    Autoimmun Rev; 2020 Mar; 19(3):102467. PubMed ID: 31918026
    [No Abstract]   [Full Text] [Related]  

  • 54. [Diagnosis and therapy for systemic sclerosis].
    Umehara H; Tanaka M; Masaki Y; Fukushima T
    Nihon Naika Gakkai Zasshi; 2007 Oct; 96(10):2165-70. PubMed ID: 18044151
    [No Abstract]   [Full Text] [Related]  

  • 55. Chronic leg ulceration as the presenting feature of diffuse systemic sclerosis in childhood.
    Wahezi DM; Ilowite NT; Kenney-Riley KM; Belamarich PF
    J Pediatr; 2011 Oct; 159(4):698. PubMed ID: 21784448
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparing ultraviolet light A photo(chemo)therapy with Methotrexate protocol in childhood localized scleroderma: Evidence from systematic review and meta-analysis approach.
    Marrani E; Foeldvari I; Lopez JA; Cimaz R; Simonini G
    Semin Arthritis Rheum; 2018 Dec; 48(3):495-503. PubMed ID: 29655520
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determinants of pulmonary function improvement in patients with scleroderma and interstitial lung disease.
    Tzelepis GE; Plastiras SC; Karadimitrakis SP; Vlachoyiannopoulos PG
    Clin Exp Rheumatol; 2007; 25(5):734-9. PubMed ID: 18078622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disease-modifying drugs for systemic sclerosis: why have we not found them yet?
    Derk CT
    Expert Rev Clin Immunol; 2011 Jul; 7(4):399-401. PubMed ID: 21790280
    [No Abstract]   [Full Text] [Related]  

  • 59. Juvenile systemic sclerosis: experience from a tertiary care center from India.
    Bagri NK; Raj D; Kaur J; Punia H; Saini I; Lodha R; Kabra SK
    Rheumatol Int; 2017 Oct; 37(10):1687-1691. PubMed ID: 28831595
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New treatments in scleroderma: the rheumatologic perspective.
    Righi A; Cerinic MM
    J Eur Acad Dermatol Venereol; 2002 Sep; 16(5):431-2. PubMed ID: 12428830
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.